AKR1C2 and neoplasm: Interestingly, there were a few studies concerning AHCY37 /NCAN38 /FBP2 /GALNT339 /AKR1C2 40 and T regulatory cells/macrophages, but most of these studies contradicted with our results in immunological manners, possibly because these studies were performed in different types of tumor.